Efficacy and safety of ritonavir-boosted dual protease inhibitor therapy in antiretroviral-naive HIV-1-infected patients: the 2IP ANRS 127 study. [electronic resource]
Producer: 20090727Description: 118-25 p. digitalISSN:- 1460-2091
- Adult
- Anti-HIV Agents -- adverse effects
- Antiretroviral Therapy, Highly Active -- adverse effects
- Asparagine -- adverse effects
- Atazanavir Sulfate
- CD4 Lymphocyte Count
- Carbamates -- adverse effects
- Female
- Furans
- HIV Infections -- drug therapy
- HIV Protease Inhibitors -- adverse effects
- HIV-1 -- drug effects
- Humans
- Male
- Middle Aged
- Oligopeptides -- adverse effects
- Organophosphates -- adverse effects
- Pyridines -- adverse effects
- Quinolines -- adverse effects
- RNA, Viral -- blood
- Ritonavir -- adverse effects
- Sulfonamides -- adverse effects
- Treatment Outcome
- Viral Load
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.